Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    Ultragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit: Investors Face April 6, 2026, Deadline

    1 day ago

    (MENAFN - PR Newswire) Did you buy RARE common stock between August 3, 2023, and December 26, 2025? Affected Ultragenyx Pharmaceutical Inc. Investor Summary Who: Ultragenyx Pharmaceutical ...
    Click here to Read More
    Previous Article
    TMC Financing Promotes Kurt Chambliss To Chief Business Development Officer
    Next Article
    Barshop Institute To Receive Up To $38 Million From ARPA-H, Anchoring UT San Antonio As A National Leader In Aging And Healthy Longevity Science

    Related World Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment